clindamycin

Drug ingredientActive Shortage

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 18323-44-9

Where It Comes From

3 FDA-registered drug labelers
Civica, Inc.
Hikma Pharmaceuticals USA Inc.
Sandoz Inc

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • •Clindamycin in 5 Percent Dextrose
FDA Shortage Status
Active Shortage
Shortage History
current

Clindamycin Phosphate Injection

03/21/2023

Unavailable

current

Clindamycin Phosphate Injection

03/21/2023

Limited Availability

current

Clindamycin Phosphate Injection

03/21/2023

Available

to be discontinued

Clindamycin Phosphate; Benzoyl Peroxide Gel

08/01/2025

to be discontinued

Clindamycin Hydrochloride Capsule

02/25/2026

to be discontinued

Clindamycin Palmitate Hydrochloride Injection

03/26/2026

current

Clindamycin Phosphate Injection

03/21/2023

Limited Availablity

to be discontinued

Clindamycin Palmitate Hydrochloride Injection

02/27/2026

Chemical Identity

CAS18323-44-9
PubChem CID446598
DTXSIDDTXSID2022836
FormulaC18H33ClN2O5S
Mol. Weight425 g/mol
SMILESCCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl

Data Sources

4465982026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/clindamycin/cids/JSON

Archive: data/sources/pubchem_name/clindamycin.json

CAS 18323-44-92026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

CAS 18323-44-92026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json

← Back to Dashboard← Back to Health